Literature DB >> 19035313

A liposomal delivery vehicle for the anticancer agent gossypol.

Guangxi Zhai1, Jun Wu, Xiaobin Zhao, Bo Yu, Hong Li, Yanhui Lu, Weiping Ye, Young C Lin, Robert J Lee.   

Abstract

BACKGROUND: Gossypol has recently been identified as a potential anticancer agent. In this study, a novel liposomal formulation is evaluated for delivery of gossypol.
MATERIALS AND METHODS: Gossypol was incorporated into liposomes. The liposomes were characterized for physical and chemical properties and for in vitro cytotoxicity.
RESULTS: Gossypol was stably encapsulated in these liposomes and exhibited cytotoxicity towards cancer cells.
CONCLUSION: Liposomes can be used effectively as gossypol carriers.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 19035313

Source DB:  PubMed          Journal:  Anticancer Res        ISSN: 0250-7005            Impact factor:   2.480


  5 in total

1.  Liposomes containing (-)-gossypol-enriched cottonseed oil suppress Bcl-2 and Bcl-xL expression in breast cancer cells.

Authors:  Hong Li; Longzhu Piao; Pingping Xu; Weiping Ye; Saiyi Zhong; Shu-Hong Lin; Samuel K Kulp; Yicheng Mao; Youngah Cho; L James Lee; Robert J Lee; Young C Lin
Journal:  Pharm Res       Date:  2011-06-28       Impact factor: 4.200

2.  Double-layered hyaluronic acid/stearic acid-modified polyethyleneimine nanoparticles encapsulating (-)-gossypol: a nanocarrier for chiral anticancer drugs.

Authors:  Hao Liu; Ke Li; Lan Lan; Jingwen Ma; Yun Zeng; Liang Xu; Daocheng Wu
Journal:  J Mater Chem B       Date:  2014-08-28       Impact factor: 6.331

Review 3.  Nanomicellar carriers for targeted delivery of anticancer agents.

Authors:  Xiaolan Zhang; Yixian Huang; Song Li
Journal:  Ther Deliv       Date:  2014-01

4.  AT101-Loaded Cubosomes as an Alternative for Improved Glioblastoma Therapy.

Authors:  Dorota K Flak; Vivian Adamski; Grzegorz Nowaczyk; Kosma Szutkowski; Michael Synowitz; Stefan Jurga; Janka Held-Feindt
Journal:  Int J Nanomedicine       Date:  2020-10-05

5.  Lipid-coated gold nanocomposites for enhanced cancer therapy.

Authors:  Ji Hee Kang; Young Tag Ko
Journal:  Int J Nanomedicine       Date:  2015-08-25
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.